558 results on '"Rosenhek, Raphael"'
Search Results
152. Standards for heart valve surgery in a ‘Heart Valve Centre of Excellence’: Table 1
153. Tricuspid Regurgitation Is Associated With Increased Risk of Mortality in Patients With Low-Flow Low-Gradient Aortic Stenosis and Reduced Ejection Fraction
154. RISK STRATIFICATION AND OUTCOMES OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
155. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer
156. CHAPTER 9 - Aortic Stenosis
157. Response to comment on: The infective endocarditis team: recommendations from an international working group by San Romanet al
158. Abstract 13983: Tricuspid Regurgitation is Independently Associated With Increased Risk of Mortality in Patients with Low-Flow Low-Gradient Aortic Stenosis and Reduced Ejection Fraction-Results From the TOPAS Study
159. Epicardial shock-wave therapy improves ventricular function in a porcine model of ischaemic heart disease
160. THE COURSE OF NT-PROBNP IN REAL-LIFE PATIENTS UNDERGOING TRANSFEMORAL AORTIC VALVE IMPLANTATION
161. Two-dimensional strain for the assessment of left ventricular function in low flow-low gradient aortic stenosis, relationship to hemodynamics, and outcome : a substudy of the multicenter TOPAS study.
162. Response to comment on : the infective endocarditis team : recommendations from an international working group by San Roman et al
163. Highlights of the 2009 scientific sessions of the European Society of Cardiology (Open Access)
164. Mutations and polymorphisms of the alpha-galactosidase A gene in patients with hypertrophic cardiomyopathy
165. Reverse Remodeling in the Perspective of Decision Making for Mitral Valve Repair With the MitraClip
166. The infective endocarditis team: recommendations from an international working group
167. Can we improve the detection of heart valve disease?
168. Outcome of Combined Stenotic and Regurgitant Aortic Valve Disease
169. Two-Dimensional Strain for the Assessment of Left Ventricular Function in Low Flow–Low Gradient Aortic Stenosis, Relationship to Hemodynamics, and Outcome
170. Epicardial shock-wave therapy improves ventricular function in a porcine model of ischaemic heart disease.
171. Chapter 23 - Aortic Stenosis: Echocardiographic Evaluation of Disease Severity, Disease Progression, and the Role of Echocardiography in Clinical Decision Making
172. Guíade práctica clínica sobre el tratamiento de las valvulopatías (versión 2012)
173. Drug-induced valvular heart disease
174. Almanac 2011: Valvular heart disease. The national society journals present selected research that has driven recent advances in clinical cardiology
175. Serum Glutathione S-Transferase P1 1 in Prediction of Cardiac Function
176. An interdisciplinary debate initiated by the European Society of Cardiology Working Group on Valvular Heart Disease
177. Valvular heart disease
178. Guía ESC/EACTS 2017 sobre el tratamiento de las valvulopatías
179. Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves
180. Watchful Waiting for Severe Mitral Regurgitation
181. BIOMARKERS OF EXTRACELLULAR MATRIX IN LOW FLOW, LOW GRADIENT AORTIC STENOSIS: RELATIONSHIP TO HEMODYNAMIC, FUNCTIONAL, AND CLINICAL OUTCOMES - RESULTS FROM THE MULTICENTER TOPAS (TRULY OR PSEUDO SEVERE AORTIC STENOSIS) STUDY
182. Prognostic value of serial B‐type natriuretic peptide measurement in asymptomatic organic mitral regurgitation
183. Management of valvular mitral regurgitation: The importance of risk stratification
184. Midterm Results of Thoracic Endovascular Aortic Repair in Patients With Aneurysms Involving the Descending Aorta Originating From Chronic Type B Dissections
185. CORRELATION OF N-TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE AND SPECKLE TRACKING DERIVED LONGITUDINAL STRAIN IN SEVERE ASYMPTOMATIC AORTIC STENOSIS
186. Natural History of Very Severe Aortic Stenosis
187. Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis
188. Highlights of the 2009 Scientific Sessions of the European Society of Cardiology
189. Direct epicardial shock wave therapy improves ventricular function and induces angiogenesis in ischemic heart failure
190. Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology Working Groups on Cardiovascular Surgery and Valvular Heart Disease.
191. Faculty Opinions recommendation of Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.
192. Big endothelin-1 is not a predictor in aortic stenosis, but is related to arterial blood pressure
193. Faculty Opinions recommendation of Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation.
194. Outcome of Watchful Waiting in Asymptomatic Severe Mitral Regurgitation
195. Faculty Opinions recommendation of Long-term vasodilator therapy in patients with severe aortic regurgitation.
196. Faculty Opinions recommendation of Exercise testing to stratify risk in aortic stenosis.
197. Statins but Not Angiotensin-Converting Enzyme Inhibitors Delay Progression of Aortic Stenosis
198. Natriuretic Peptides Predict Symptom-Free Survival and Postoperative Outcome in Severe Aortic Stenosis
199. 1107-138 Statin therapy does not affect bioprosthetic valve degeneration
200. Doppler gradient estimations across tunnel obstructions: An in vitro study including flow visualization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.